http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108685879-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2018-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108685879-B
titleOfInvention Rivastigmine transdermal patch and preparation method thereof
abstract The invention discloses a rivastigmine transdermal patch and a preparation method thereof, the method comprises dispersing rivastigmine or salt thereof, phospholipid and water-soluble auxiliary materials in an organic solvent, and removing the solvent by a spray drying method or a reduced pressure drying method to prepare powder; preparing an adhesive layer consisting of liquid paraffin and a styrene-isoprene-styrene block copolymer, heating the adhesive layer composition at the temperature of 55-70 ℃ for 2-10 h, uniformly filling the medicine powder on the surface of the adhesive layer, and cooling to the normal temperature at the average cooling speed of 1-15 ℃/h to prepare the transdermal patch. The pharmaceutical composition prepared by the invention can inhibit the precipitation of active drug crystals in the patch with high drug loading capacity as much as possible, improve the transdermal release rate of the active drug rivastigmine, and has small drug irritation.
priorityDate 2018-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009101412-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17233
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54680660
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6586
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409704282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414100136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID510761
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID65047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525623

Total number of triples: 41.